EP0746361A1 - Dispositif d'alimentation par voie enterale - Google Patents

Dispositif d'alimentation par voie enterale

Info

Publication number
EP0746361A1
EP0746361A1 EP94916527A EP94916527A EP0746361A1 EP 0746361 A1 EP0746361 A1 EP 0746361A1 EP 94916527 A EP94916527 A EP 94916527A EP 94916527 A EP94916527 A EP 94916527A EP 0746361 A1 EP0746361 A1 EP 0746361A1
Authority
EP
European Patent Office
Prior art keywords
tube
tubes
feeding
coated
gastrostomy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94916527A
Other languages
German (de)
English (en)
Inventor
Donald Jay Goldhardt
William Henry Hirsch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of EP0746361A1 publication Critical patent/EP0746361A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A61L29/085—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J15/00—Feeding-tubes for therapeutic purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J15/00—Feeding-tubes for therapeutic purposes
    • A61J15/0026—Parts, details or accessories for feeding-tubes
    • A61J15/003—Means for fixing the tube inside the body, e.g. balloons, retaining means
    • A61J15/0034—Retainers adjacent to a body opening to prevent that the tube slips through, e.g. bolsters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J15/00—Feeding-tubes for therapeutic purposes
    • A61J15/0026—Parts, details or accessories for feeding-tubes
    • A61J15/0069—Tubes feeding directly to the intestines, e.g. to the jejunum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J15/00—Feeding-tubes for therapeutic purposes
    • A61J15/0003—Nasal or oral feeding-tubes, e.g. tube entering body through nose or mouth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J15/00—Feeding-tubes for therapeutic purposes
    • A61J15/0015—Gastrostomy feeding-tubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J15/00—Feeding-tubes for therapeutic purposes
    • A61J15/0026—Parts, details or accessories for feeding-tubes
    • A61J15/003—Means for fixing the tube inside the body, e.g. balloons, retaining means
    • A61J15/0034—Retainers adjacent to a body opening to prevent that the tube slips through, e.g. bolsters
    • A61J15/0038—Retainers adjacent to a body opening to prevent that the tube slips through, e.g. bolsters expandable, e.g. umbrella type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J15/00—Feeding-tubes for therapeutic purposes
    • A61J15/0026—Parts, details or accessories for feeding-tubes
    • A61J15/003—Means for fixing the tube inside the body, e.g. balloons, retaining means
    • A61J15/0034—Retainers adjacent to a body opening to prevent that the tube slips through, e.g. bolsters
    • A61J15/0038—Retainers adjacent to a body opening to prevent that the tube slips through, e.g. bolsters expandable, e.g. umbrella type
    • A61J15/0042—Retainers adjacent to a body opening to prevent that the tube slips through, e.g. bolsters expandable, e.g. umbrella type inflatable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J15/00—Feeding-tubes for therapeutic purposes
    • A61J15/0026—Parts, details or accessories for feeding-tubes
    • A61J15/0073—Multi-lumen tubes

Definitions

  • the present invention relates generally to a tube for use in the enteral feeding of a nutritional product directly into the gastrointestinal tract, and more particularly to an enteral feeding tube coated with a poly(p- xylene) polymer.
  • a first example of a tube for use in the enteral feeding of a liquid nutritional product directly into the gastrointestinal tract is a nasogastric tube, which may extend through a patient's nasal cavity, down the esophagus to the stomach.
  • a second example of a tube for use in the enteral feeding of a liquid nutritional product directly into the gastrointestinal tract is a gastrostomy tube which may extend through a patient's abdominal wall and stomach wall for feeding directly into the stomach.
  • a third example of a tube for use in the enteral feeding of a liquid nutritional product directly into the gastrointestinal tract is a jejunostomy tube which may extend either through the lumen of a gastrostomy tube and thence into the patient's intestine, or through the patient's abdominal wall and intestinal wall, in either case facilitating feeding directly into the intestine.
  • a tube for enteral feeding of a liquid nutritional product directly into the gastrointestinal tract may have to be removed is clogging primarily due to the coagulation of an enteral nutritional food product.
  • a second reason is degradation of the tube.
  • a patient may accidentally or intentionally remove a feeding tube thus requiring the insertion of a replacement tube. Premature replacement of a feeding tube causes the patient to be subjected to the inconvenience, cost, and retraumatization associated with this procedure.
  • a tube for use in enteral feeding directly into the stomach or intestine of a mammal comprising a tubular member having an inner and an outer surface, said inner surface being coated with a substituted and/or unsubstituted poly(p-xylene) polymer.
  • the outer surface of the tube is coated with said poly(p-xylene) polymer.
  • the present invention provides a tube for enteral feeding directly into the stomach or intestine of a mammal which reduces the problems associated with clogging and with degradation, and lessens the frequency of replacement of enteral tube feeding devices due to these problems.
  • Fig. 1 is a perspective view of a gastrostomy tube in accordance with the present invention.
  • Fig. 2 is a longitudinal cross sectional view taken on a greatly enlarged scale along line 2-2 of Fig. 1.
  • Fig. 3 is a longitudinal cross sectional view similar to Fig. 2, but of a modified embodiment of the invention.
  • Fig. 4 is a fragmentary cross-section of a conventional tube following testing over a period of months.
  • Fig. 5 is a fragmentary cross-section of a tube in accordance with the present invention along line 5-5 of Fig. 2.
  • Fig. 6 is a fragmentary cross-section of a tube in accordance with the present invention along line 6-6 of Fig. 3.
  • Fig. 7 is a perspective view of another gastrostomy tube which may be employed in the practice of the present invention.
  • Fig. 8 is a diagrammatic representation of a jejunal feeding tube which may be employed in the practice of the present invention.
  • Fig. 9 is a diagrammatic representation of a jejunostomy tube which may be employed in the practice of the present invention.
  • Fig. 10 is a perspective view of a device for feeding a nutritional product directly into the stomach which may be employed in the practice of the present invention.
  • Fig. 11 is a diagramatic representation of a nasogastric tube which may be employed in the practice of the present invention.
  • tubes used for the enteral feeding of liquid nutritional products into the stomach or intestine of a mammal such as gastrostomy tubes
  • clogging of the tube can be caused by coagulated enteral nutritional formulas, or by crushed medications or other solids introduced into the tube.
  • users of such tubes may flush a clogged feeding tube with a fluid, such as water, in an attempt to restore the patency of the lumen. If the flushing is unsuccessful, the tube is generally replaced with a new one. Thus the patient is subjected to the inconvenience, cost and trauma associated with the replacement procedure.
  • Enteral feeding tubes are typically comprised of silicone rubber, and microorganisms, such as Candida tropicalis, Candida albicans, Torulopsis glabrata, and others can attach themselves to the surface of the silicone rubber. Under normal patient health conditions, these microorganisms pose no problems. However, in patients whose immune systems may be compromised (for example - cancer or AIDS patients) microorganisms can proliferate internally and the patient cannot fight them with their normal immune systems.
  • microorganisms only cause a problem after they have been introduced into a patient's body, but that is more easily done than might be expected.
  • skin yeasts can be present on unclean hands, such that hand contact with the food inlet port may accidently introduce yeast into the tube. This accidental contact can occur when cleaning the area, or by improper handling of the tube.
  • elastomeric properties e.g. tensile strength, hoop strength, recovery, etc.
  • the tube loses its hoop strength resulting in a misshapen tube.
  • loss of its elastomeric properties causes the tube to be more easily flattened, especially if nurses attempt to slide crushed medications through the tube by squeezing the tube.
  • Figs. 1 and 2 illustrate an example of a gastrostomy tube embodying this invention designated generally by the numeral 10.
  • This gastrostomy tube 10 is an example of a replacement, or secondary, gastrostomy tube which is employed when the patient already has a healthy, mature stoma tract.
  • the replacement gastrostomy tube may be inserted into the stomach through the stoma following the removal of a primary gastrostomy tube, which will be described later.
  • the basic components of this exemplary device are a tubular member 12 having an outer surface wall 13, with the tubular member 12 enclosing a feeding lumen 14 and a fluid flow channel 16.
  • the fluid flow channel 16 is also referred to in the trade as a balloon lumen.
  • the port housing includes as its primary components, a main food inlet port 20 equipped with a main port closure 21, a Y-port 22 similarly equipped with a Y-port closure 23, and a fluid inlet port 25 equipped with a valve means 26 preferably of the type known as a one-way valve.
  • a valve means 26 preferably of the type known as a one-way valve.
  • An expandable component member 38 often referred to as a balloon, is secured preferably by means of an adhesive bond 39 to outer surface wall 13.
  • a fluid access port 40 extends between the fluid flow channel 16 and the outer surface wall 13 located centrally of the expandable component member. As such, the fluid flow channel is capable of passing fluid from the valve means 26 shown in Fig. 1 into expandable component member 38 so as to permit the expansion of the balloon.
  • a retention device 43 is also provided having a triangular configuration and a plurality of vent holes.
  • a device for enteral feeding according to the present invention is preferably fabricated from 100% medical grade silicone rubber, with the exception of the coating which is described below and the components of the valve means 26.
  • Fig. 2 discloses this invention comprising a layer 50 of a poly(p-xylene) polymer (parylene) on the inner surface of the tubular member.
  • a layer 60 of a poly(p-xylene) polymer coats the outer surface of the tubular member.
  • Poly(p-xylene) polymers are well known.
  • the preferred choice for this invention is the parylene supplied by Specialty Coating Systems (a subsidiary of Union Carbide) of Indianapolis, Indiana. Parylene has been used to coat orthopedic products to render their materials compatible with body tissue, and to serve as a dry film lubricant.
  • Patents involving parylene or poly(p-xylene) polymers include U.S. Patent No. 3,826,244 to Salcman et al for Thumbtack Microelectrode and Method of Making Same, and U.S. Patent No. 4,225,647 for Articles Having Thin, Continuous, Impervious Coatings.
  • the parylene is coated onto an outer and/or inner wall of a tubular member by a deposition process.
  • First the parylene is heated to approximately 150°C at 1 Torr, resulting in conversion to a gaseous dimer.
  • the dimeric gas is forced downstream into a pyrolysis zone as the gas pressure in the vaporization zone rises. In the pyrolysis zone the temperature rises to approximately 690°C at 0.5 Torr, thereby splitting the dimeric molecules into highly reactive monomers.
  • parylene-N is used.
  • the monomer molecules continue to respond to pressure, flowing into the deposition chamber where they disperse, deposit and polymerize into a clear linear film on all surfaces which are exposed to the gas.
  • Deposition takes place in a vacuum environment of approximately 0.1 Torr and near ambient temperature (approximately 35°C) . Coating thickness is relatively uniform, with excellent conformity.
  • the tubular member has its entire inner surface coated except for portions located within about 1.3 cm (1/2") from the first end and the second end.
  • Each of the tubes were contaminated (for purposes of this study) with an enteral nutritional product in which yeasts, isolated from a tube removed from a patient in a clinical environment, were suspended. Re-contamination with yeasts was repeated on a weekly basis for the first several months of the trial. Then, in an attempt to more accurately model a clinical environment, and to hasten the breakdown of the tubes, various bacteria, also isolated from clinical tubes, including Escherichia coli, Enterobacter, Serratia, Citrobacter, Klebsiella, and Pseudo onas were suspended with the yeast in the enteral nutritional product, and recontamination of the tubes was repeated on a daily basis. This occurred approximately four and one-half months after the test began.
  • the parylene coated tubes prior to the test appeared to be somewhat less pliable when squeezed than the fresh, uncoated tubes. Meanwhile, the conventional tubes had a soft, rubbery feel. Over the next couple of months, no changes were readily detected. However, in the time period prior to cessation of the study, the conventional tubes began to lose some of their roundness and appeared to be somewhat bumpy. Also, following squeezing of the conventional tubes, the walls did not spring back to their natural round shape as quickly as before. The poly (p-xylene) polymer coated tubes did not experience any noticeable decline with respect to their physical characteristics.
  • the second test involved the growing of cultures on various m ia using coagulum from the tubes. This test was performed in order to identify the contaminating microorganisms. Coagulum was plated on blood agar, MacConkey agar and Sabouraud's agar with gentamicin plates. Blood agar medium is a non-selective medium which allows most aerobic organisms to grow. In this study, culture on blood agar medium resulted in the isolation of yeast and diphtheroids. MacConkey agar permits the growth of gram-negative enteric bacteria, but none were isolated following culture, even after inoculation of the enteral nutritional formula therewith. Only yeasts were isolated on the MacConkey agar.
  • the Sabouraud's medium with gentamicin permits the growth of yeasts and inhibits the growth of most bacteria. Only yeasts were isolated. Overall, the results of the cultures (shown below in Tables 1 and 2) indicated that each tube (coated and uncoated) contained yeast and gram-positive bacteria, but no gram-negative organisms. Thus the icrobial culture results confirmed the morphological data of the organisms observed in the gram-stained smears of the coagulum. The cultures also corroborated the failure to establish gram-negative bacteria in any of the silicone tubes.
  • Tube 4 Yeast - 3 Yeast - 2 Yeast - 3
  • the third test involved a longitudinal incision of each of the tube segments.
  • the conventional uncoated tubes subjected to this test lost some elasticity and remained open after a longitudinal incision.
  • the appearance of the conventional uncoated tubes subjected to this test and then cut longitudinally resembles the look of tubes from clinical sources when cut longitudinally.
  • a parylene coated tube subjected to the same testing procedure remained in apposition when a longitudinal cut was made, indicating that the wall of the tube was not weakened.
  • the fourth test involved a visual comparison of the interior walls of the tubes. Swabs were used to clean the inner surface of the tubes.
  • the inner surfaces of all the conventional uncoated tubes had focal to more generalized yellowish deposits. These were deposits of the coagulated enteral nutritional product, within which were yeasts. In contrast, the parylene coated tubes were free from deposits. The inner surfaces had the same white color that was present prior to the study.
  • the fifth test involved the microscopic evaluation of sections of the tubes.
  • Cross sections of previously cleaned tubes were immersed in acetone for approximately 2 minutes, air dried, then immersed in Wright stain for 30 seconds to 1 minute. After washing and drying, the sections were placed on a glass slide surrounded by methacrylate polymer mounting fluid and covered with a cover glass.
  • the tube degradation was visually assessed. Focal to more generalized areas of penetration by microganisms into the conventional tubes were observed, typically involving 75-85% of the inner surface of the tube. This finding coincided with the depth of penetration often involving up to 20% of the width of the conventional tubes in some areas as shown in Fig. 4, which is a cross sectional representation of the tube degradation 99 which was observed in conventional uncoated tubes.
  • Figs. 5 and 6 are representative cross- sections of the lack of degradation which was observed in any of the parylene coated tubes.
  • Fig. 5 is a cross-section of the embodiment of Fig. 2 taken along line 5-5 thereof
  • Fig. 6 is a cross-section of the embodiment of Fig. 3 taken along line 6-6 thereof.
  • Tube 1 80-85% of tube inner surface involved; 10-30% depth of penetration
  • Tube 2 80-85% of tube inner surface involved; 10-25% depth of penetration
  • Tube 3 80-85% of tube inner surface involved; 10-20% depth of penetration
  • Tube 1 No focal or generalized areas involved; no evidence of penetration or growth into the wall; some cracks noted
  • Tube 2 No focal or generalized areas involved; no evidence of penetration or growth into the wall; some cracks noted
  • Tube 3 No obvious focal or generalized areas involved; one area of possible penetration or growth into the wall; but could be an artifact; some cracks noted
  • Tube 4 No focal or generalized areas involved; one area of possible penetration or growth into the wall; but could be an artifact; some cracks noted
  • the parylene coated feeding tubes are superior to the feeding tubes conventionally used today.
  • the feeding tubes of this invention do not develop deposits on the inner surface associated with conventional enteral feeding tubes. Additionally, there was evidence of penetration of the inner wall in the conventional tubes, and an apparent loss of elasticity.
  • the parylene coated tubes were (with the exception of a single focal area in one tube) free of microbial penetration of the inner wall surface. In conclusion, in terms of tube degradation due to microbial contamination, the parylene coated tubes outperformed the conventional uncoated tubes.
  • Figs. 7-11 there is shown a variety of additional devices for enteral feeding directly into the gastrointestinal tract of a mammal which may be employed in the practice of the present invention. These devices are only exemplary and one skilled in the art will immediately recognize that a variety of embodiments of such devices are known which could be employed in the practice of the present invention.
  • Fig. 7 is a perspective view of a primary gastrostomy tube 100.
  • a primary gastrostomy tube of the type shown may be installed, for example, by means of a percutaneous endoscopic gastrostomy (PEG) .
  • PEG percutaneous endoscopic gastrostomy
  • a gastrostomy tube of the type shown in Fig. 1 may be employed as a primary gastrostomy tube when placed by a laparoscopic gastrostomy procedure.
  • a primary gastrostomy tube is a device used for the initial placement in the patient of an enteral feeding tube which passes through the abdominal wall into the stomach.
  • One objective of the use of a primary gastrostomy tube is the formation of a healthy, mature stoma tract which may later facilitate the placement of a replacement, or secondary, gastrostomy tube as has already been described herein.
  • FIG. 7 an assembly comprising a primary gastrostomy tube 100 and a tapered dilator 101.
  • the tubular portion 102 were to be comprised of a material of sufficient rigidity, it could be configured to function as a dilator. However; inasmuch as the preferred materials for the tubular portion 102 are fairly soft and flexible, it is preferred that the dilation of a stoma formed during a PEG procedure is better accomplished by using a tapered dilator 101 of a more rigid material such as a low or medium density polyethylene.
  • An internal retaining member 103 is located at the end of the primary gastrostomy tube which will be disposed within a patient's stomach when the tube is in its operative position.
  • the end 104 of the tubular member 102 which will be disposed externally of the patient's abdomen is joined to the larger end 105 of the tapered dilator 101 by a means for connecting such as a barbed nylon connector 106.
  • a means for connecting such as a barbed nylon connector 106.
  • Such a primary gastrostomy tube has been described in U.S. Patent 5,080,650. It is the tubular portion 102 of the primary gastrostomy tube which may advantageously be coated with a substituted and/or unsubstituted poly (p-xylene) polymer in accordance with the present invention.
  • a jejunal feeding tube 109 with the primary gastrostomy tube 100 which has been installed with its internal retaining member 103 disposed within the stomach 110 of a patient.
  • the excess length of the gastrostomy tube has been cut off to such that about 15 cm of the gastrostomy tube is located exterior of the patient's abdomen.
  • Feeding of the patient may then commence by passing a jejunal feeding tube 109 through the gastrostomy tube 100 into the stomach 110, past the pyloris and into the small bowel. Once in the small bowel the jejunal feeding tube 109 passes through the duodenum 111 and preferably terminates in the area of the jejunum 112.
  • a jejunal feeding tube may advantageously be coated with a substituted and/or unsubstituted poly (p- xylene) polymer in accordance with the present invention.
  • a jejunostomy tube 115 in its operative position extending through the abdominal wall 116 of a patient into the patient's jejunum 117.
  • the patient's jejunum is secured against the abdominal wall by retaining devices having an internal T-member 118 secured to an external member 119 by a suture 120.
  • the jejunostomy tube 115 is secured by a suitable retaining device 121.
  • Located at the external end of the jejunostomy tube is a port 122 for receiving a nutritional product.
  • a jejunostomy tube may be installed, for example, using a laparoscopic procedure of the type taught in U.S. Patent 5,151,086.
  • the tubular portion of a jejunostomy tube is typically comprised of polyurethane.
  • the tubular portion of a jejunostomy tube may advantageously be coated with a substituted and/or unsubstituted poly (p- xylene) polymer in accordance with the present invention.
  • FIG. 10 there is shown a perspective view of an example of a type of replacement gastrostomy tube 130 having a tubular portion 131, a stretchable internal retaining portion 132 (which is located inside the stomach when installed) and an external retaining member 133 (which is located adjacent to, and external of the patient's abdomen when installed).
  • a stopper member 134 is used to plug the feeding lumen between feedings.
  • Such replacement gastrostomy tubes have been marketed by Ross Laboratories, a Division of Abbott Laboratories, Columbus, Ohio, U.S.A.
  • the tubular portion of this type of replacement gastrostomy tube may advantageously be coated with a substituted and/or unsubstituted poly (p-xylene) polymer in accordance with the present invention.
  • a nasogastric tube 140 which extends through a patient's nasal cavity 141 and esophagus 142 to the stomach 143, and may further extend if desired into the intestine 144 (if placed in the intestine the tube may also be referred to as a nasogastrointestinal tube) .
  • a nasogastric tube may be employed in enterally feeding directly into the patient's gastrointestinal tract.
  • the tubular portion of a nasogastric tube is typically comprised of polyurethane.
  • a nasogastric (or nasogastrointestinal) tube may advantageously be coated with a substituted and/or unsubstit ited poly (p-xylene) polymer in accordance with the present invention.
  • the enteral feeding industry has long sought ways to reduce retraumatization due to replacement of feeding tubes. Additionally, the industry has sought ways to minimize the potential for problems due to tube clogging and degradation. This invention solves the long felt need. All the advantages of this invention would be found extremely beneficial by physicians, and more importantly by patients.
  • the invention could, for example, take the form of a gastrostomy tube, a replacement gastrostomy tube, a jejunal feeding tube, a nasogastric tube or jejunostomy tube. Additionally the tubes could be of PVC, latex rubber, or polyurethane.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

L'invention concerne un dispositif (10) d'alimentation par voie entérale pour une alimentation directe dans le tractus gastro-intestinal à l'aide d'un tube (12) ayant une surface externe (13) et une surface interne. La surface interne délimite un canal d'alimentation (14) et elle porte un revêtement en polymère (50) de type poly(p-xylène) substitué ou/et non substitué retardant la détérioration et l'obstruction du dispositif. Comme exemples de tels dispositifs, on peut citer les tubes nasogastriques et les tubes pour gastrostomie ou jéjunostomie.
EP94916527A 1993-08-05 1994-04-12 Dispositif d'alimentation par voie enterale Withdrawn EP0746361A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10301293A 1993-08-05 1993-08-05
US103012 1993-08-05
PCT/US1994/003997 WO1995004564A1 (fr) 1993-08-05 1994-04-12 Dispositif d'alimentation par voie enterale

Publications (1)

Publication Number Publication Date
EP0746361A1 true EP0746361A1 (fr) 1996-12-11

Family

ID=22292888

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94916527A Withdrawn EP0746361A1 (fr) 1993-08-05 1994-04-12 Dispositif d'alimentation par voie enterale

Country Status (2)

Country Link
EP (1) EP0746361A1 (fr)
WO (1) WO1995004564A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2783708B1 (fr) * 2001-01-24 2016-03-30 Becton Dickinson and Company Septum élastomère avec revêtement polymère
DE10131152B4 (de) * 2001-04-30 2004-05-27 Nutricia Healthcare S.A. Medizinisches Ballon-Button-System
PL1935355T3 (pl) * 2006-12-11 2016-03-31 Nutricia Nv Rurka do żywienia dojelitowego
US8128599B2 (en) 2007-07-20 2012-03-06 Tyco Healthcare Group Lp Lubricious coatings
US9283151B2 (en) 2009-10-23 2016-03-15 Louis O. Porreca, JR. Enteral feeding tube having unclogging lumen
WO2019173819A1 (fr) * 2018-03-09 2019-09-12 University Of Connecticut Dispositif nasogastrique et méthode

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863424A (en) * 1983-11-18 1989-09-05 Blake Joseph W Iii Tubular medical device and method of making and using the same
US4668225A (en) * 1985-12-23 1987-05-26 Superior Healthcare Group, Inc. Gastrostomy tube and gastrostomy-jejunal feeding tube combination
US4698056A (en) * 1986-03-21 1987-10-06 Medi-Tech, Inc. Enteric feeding device
US5032113A (en) * 1989-04-13 1991-07-16 Scimed Life Systems, Inc. Innerless catheter

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9504564A1 *

Also Published As

Publication number Publication date
WO1995004564A1 (fr) 1995-02-16

Similar Documents

Publication Publication Date Title
AU780339B2 (en) Silicone elastomer material for use with enteric feeding device
Baskin Acute complications associated with bedside placement of feeding tubes
Nakad et al. Is early enteral nutrition in acute pancreatitis dangerous? About 20 patients fed by an endoscopically placed nasogastrojejunal tube
EP0228762A1 (fr) Dispositif d'intubation portant un revêtement de lubrifiant et sa méthode de fabrication
CA2229521A1 (fr) Article avec revetement antimicrobien; production et emploi
Berkovits et al. Caustic injury of the oesophagus. Sixteen years experience, and introduction of a new model oesophageal stent
EP0287998A3 (fr) Cathéter-gastrique/duodénal/jéjunal, pour l'alimentation entérique percutanée
EP2468319A1 (fr) Nouveau nano-produit utile dans la prophylaxie, diagnostic et traitement médical et vétérinaire
CH617856A5 (fr)
CA2007118C (fr) Dispositif de mesure des stomies
Anderton Bacterial contamination of enteral feeds and feeding systems
Challacombe et al. Bacterial microflora of the upper gastrointestinal tract in infants without diarrhoea
Farrelly et al. Complications in pediatric enteral and vascular access
EP0746361A1 (fr) Dispositif d'alimentation par voie enterale
EP1729715A1 (fr) Dispositifs de liberation et methodes de liberation de liquides et de nutriments a des patients
JP2008006006A (ja) 生体内留置チューブ
Gottlieb et al. Intraluminal fungal colonization of gastrostomy tubes
Qureshi et al. Trichobezoar–a condition to think of in case of mobile abdominal mass
Adegboye et al. Transhiatal esophagectomy in children with corrosive esophageal stricture
Binder et al. Experience with silicone rubber-coated Foley urethral catheters
Yadav et al. Clean intermittent catheterisation for the neuropathic bladder
Wirth et al. Necrotizing Candida infection after percutaneous endoscopic gastrostomy: a fatal and rare complication
Roudaut Residues of aminoglycoside antibiotics in eggs after medication of laying hens
Beattie et al. Aspiration (of gastric residuals)—a cause of bacterial contamination of enteral feeding systems?
Donlan Problems of biofilms associated with medical devices and implants

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960514

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19971101